BRAF-V600E DEGRADATION AS A THERAPEUTIC STRATEGY IN BRAF-V600E MUTANT GLIOMAS

被引：0
|
作者：
Zhao, Guisheng [1 ]
Muldoon, Daniel [1 ]
Mo, Xiulei [2 ]
Tang, Cong [2 ]
Fu, Haian [2 ]
Gustafson, W. Clay [3 ]
Weiss, William A. [3 ]
Nicolaides, Theodore [1 ]
机构：
[1] New York Univ Langone Hlth, Dept Pediat, New York, NY USA
[2] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA
[3] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
THER-17
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [21] A Tale of Two Cases - BRAF-V600E Targeted Therapy in Iowa
    Harmoney, Kathryn
    Al-Huniti, Ahmad
    Clepp, Jason
    Modi, Arunkumar
    Sato, Mariko
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S91 - S92
  • [22] A promising targeted therapy for metastatic melanoma with BRAF-V600E mutation
    Darbon, J. -M.
    BULLETIN DU CANCER, 2010, 97 (12) : 1413 - 1414
  • [23] Pancreatic acinar carcinoma - a rare entity with a targetable BRAF-V600E mutation
    Florou, Vaia
    Nevala-Plagemann, Chris
    Mulvihill, Sean
    Garrido-Laguna, Ignacio
    CANCER RESEARCH, 2020, 80 (16)
  • [24] Induction of Resistance to BRAF Inhibitor Is Associated with the Inability of Spry2 to Inhibit BRAF-V600E Activity in BRAF Mutant Cells
    Ahn, Jun-Ho
    Han, Byeal-I
    Lee, Michael
    BIOMOLECULES & THERAPEUTICS, 2015, 23 (04) : 320 - 326
  • [25] Suppression of oncogene transcription - PNA as targeted cancer therapy for BRAF-V600E mutant melanoma
    Rothman, J. H.
    Surriga, O.
    Ambrosini, G.
    Vasudeva, S.
    Schwartz, G. K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [26] SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis
    Kevin Tong
    Om A. Kothari
    Katherine S. Haro
    Anshuman Panda
    Manisha M. Bandari
    Jillian N. Carrick
    Joseph J. Hur
    Lanjing Zhang
    Chang S. Chan
    Jinchuan Xing
    Michael L. Gatza
    Shridar Ganesan
    Michael P. Verzi
    Oncogene, 2021, 40 : 6034 - 6048
  • [27] Langerhans cell sarcoma with BRAF-V600E mutation and hemophagocytosis: An autopsy report
    Madakshira, Manoj
    Sharma, Navneet
    Malhotra, Pankaj
    Bal, Amanjit
    INDIAN JOURNAL OF CANCER, 2022, 59 (01) : 119 - 122
  • [28] Clinicopathological factors associated with BRAF-V600E mutation in colorectal serrated adenomas
    Travaglino, Antonio
    D'Armiento, Francesco P.
    Cassese, Gianluca
    Campanino, Maria R.
    Borrelli, Giorgio
    Pignatiello, Sara
    Luglio, Gaetano
    Maione, Francesco
    De Palma, Giovanni D.
    D'Armiento, Maria
    HISTOPATHOLOGY, 2019, 75 (02) : 160 - 173
  • [29] BRAF-V600E MUTATION IN HAIRY CELL LEUKEMIA: PATHOGENETIC AND CLINICAL IMPLICATIONS
    Tiacci, Enrico
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (06) : 378 - 378
  • [30] KRK with BRAF-V600E Mutation: Triple Therapy prolongs Overall Survival
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (02) : 75 - 76
12345